PRZ-TADALAFIL

pharmaris canada inc🇨🇦 Health Canada

Approval Id: 9e4467bb12680445
Drug Approval Canada Name: PRZ-TADALAFIL
Product Name: PRZ-TADALAFIL
Status: Marketed
Status Date: 2021-09-27
Original Market Date: 2021-09-27
Din: 02512262
Drug Class: Human
Dosage Form: Tablet
Route Of Administration: Oral
Schedule: Prescription
Ahfs: 24:12.12
Atc Original: G04BE08 TADALAFIL
Atc Name: g 04 be 08
Aig Number: 0149485003
Company Name: pharmaris canada inc
Company Address: 102, 8310 130th Street, Surrey, British Columbia, Canada, V3W 8J9

TADALAFIL

2.5 MG

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

9e4467bb12680445

Type

Standard